Read More Analyst Ratings News Price Target JMP Securities Maintains Market Outperform on CyberArk Software, Raises Price Target to $214 By Benzinga Newsdesk October 27, 10:14 AM JMP Securities analyst Erik Suppiger maintains CyberArk Software (NASDAQ:CYBR) with a Market Outperform and raises the price target from $173 to $214. CYBR
Read More Earnings Global Guidance News This Chinese EV Maker Expects To Sell More Cars Than Nio, XPeng In Q3 By Shanthi Rexaline August 30, 11:04 AM The U.S.-listed Chinese electric vehicle startups Nio, Inc. (NYSE: NIO) and XPeng, Inc. (NYSE: XPEV) invariably steal peer Li Auto Inc. LI
Read More FDA News Biomerica Says Expects Completion Of Patient Enrollment For InFoods Diagnostic-Guided Therapy Irritable Bowel Syndrome Clinical Trial this week By Benzinga Newsdesk August 30, 8:19 AM Biomerica Inc. (NASDAQ:BMRA) today announced it expects final patient enrollment in its endpoint clinical trial for its InFoods® diagnostic-guided therapy (DGT), designed to alleviate Irritable Bowel Syndrome BMRA
Read More Analyst Color Analyst Ratings Downgrades Movers News Price Target Tech Trading Ideas Piper Sandler Considers Cloudflare As Fairly Valued, Downgrades To Neutral By Anusuya Lahiri October 11, 8:28 AM Piper Sandler analyst James Fish downgraded Cloudflare (NYSE:NET) to Neutral from Overweight with a price target of $141, up from $125, implying an… AMZN